This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Nov 15;68(9):1228-9.

doi: 10.1097/00007890-199911150-00002.

The new-generation therapeutic anti-CD25 monoclonal antibodies

K A Williams¹, M A Thiel, H Zola

Affiliations

PMID: 10573055
DOI: 10.1097/00007890-199911150-00002

Comment

The new-generation therapeutic anti-CD25 monoclonal antibodies

K A Williams et al. Transplantation. 1999.

. 1999 Nov 15;68(9):1228-9.

doi: 10.1097/00007890-199911150-00002.

Authors

K A Williams¹, M A Thiel, H Zola

Affiliation

¹ Department of Ophthalmology, Flinders University, Adelaide, Australia.

PMID: 10573055
DOI: 10.1097/00007890-199911150-00002

No abstract available

PubMed Disclaimer

Comment on

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group.
Kovarik JM, Kahan BD, Rajagopalan PR, Bennett W, Mulloy LL, Gerbeau C, Hall ML. Kovarik JM, et al. Transplantation. 1999 Nov 15;68(9):1288-94. doi: 10.1097/00007890-199911150-00012. Transplantation. 1999. PMID: 10573065 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information